A61K 31/7034
Attached to a carbocyclic compound
Official title: attached to a carbocyclic compound, e.g. phloridzin
A61K31/7034 (Attached to a carbocyclic compound) appears on 4,003 US grants and 7,771 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,003
- Published applications
- 7,771
- Assignees
- 3,038
- Inventors
- 13,927
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 10 | 0 |
| 1998 | 22 | 0 |
| 1999 | 24 | 0 |
| 2000 | 20 | 0 |
| 2001 | 33 | 14 |
| 2002 | 36 | 77 |
| 2003 | 47 | 137 |
| 2004 | 34 | 163 |
| 2005 | 45 | 217 |
| 2006 | 48 | 188 |
| 2007 | 33 | 179 |
| 2008 | 56 | 164 |
| 2009 | 53 | 171 |
| 2010 | 83 | 221 |
| 2011 | 87 | 236 |
| 2012 | 124 | 257 |
| 2013 | 141 | 325 |
| 2014 | 213 | 386 |
| 2015 | 210 | 420 |
| 2016 | 256 | 516 |
| 2017 | 274 | 488 |
| 2018 | 281 | 426 |
| 2019 | 282 | 433 |
| 2020 | 276 | 434 |
| 2021 | 240 | 485 |
| 2022 | 241 | 496 |
| 2023 | 225 | 437 |
| 2024 | 210 | 365 |
| 2025 | 219 | 313 |
| 2026 | 125 | 223 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Therapeutic uses of inhibitors of the RNA-binding protein HuR6 Oct 2026US 12,751,938 B2University of Kansas
- Aqueous pharmaceutical compositions comprising SGLT-2 inhibitors29 Sep 2026US 12,746,198 B2
- Combinatory treatment29 Sep 2026US 12,746,216 B2Arivin Therapeutics Oy
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Guanidinylated Amphiphilic Tobramycin Derivates and B-Lactam/B-Lactamase Inhibitor Combinations for Treatment of Pseudomonas Aeruginosa Infections8 Oct 2026US 2026/0306524 A1
- Combination therapy glucocorticoids and ginsenoside8 Oct 2026US 2026/0306525 A1Fytagoras
- A combination therapy for cancer treatment8 Oct 2026US 2026/0306633 A1Purdue Research Foundation
- Systems and methods for targeted breast cancer therapies1 Oct 2026US 2026/0294809 A1American University of Sharjah
- Remote control and quantitative monitoring of drug release from nanoparticles based on magnetic particle imaging1 Oct 2026US 2026/0294836 A1Board of Trustees of Michigan State University
Most cited
By later US patents
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Liquid delivery compositions268US 5,780,044 AAtrix Laboratories, Inc. · 1998
- Formulations and methods for providing prolonged local anesthesia261US 5,942,241 AEuro-Celtique S. A. · 1999